A health care program for the investigation and treatment of elderly women with urinary incontinence and related urogenital symptoms.
The assessment and treatment of urinary incontinence and related urogenital symptoms using an algorithm model was evaluated in 364 elderly women complaining of urinary incontinence. The women (age 72.1 +/- 1.5 years, range 65-84 years) were assessed by a 48-hour pad test, a cough provocation test, micturition lists and a gynecological examination which included a smear test, measurement of vaginal pH and bacterial cultures. The diagnosis of urinary incontinence was confirmed in 346 women (stress 26.3%; urge: 32.7%; mixed: 41.0%). Women suffering from stress incontinence were younger (p less than 0.05) and had experienced a larger number of deliveries (p less than 0.05) than women with urge incontinence. All the women were treated with oral estriol, 3 mg daily for 4 weeks followed by 1-2 mg daily. The total urinary leakage per 48 hours (p less than 0.01) and maximum single leakage (p less than 0.05) were reduced in women with mixed incontinence, while the frequency of micturition decreased (p less than 0.05) in women with urge incontinence after 12 weeks treatment with oral estriol. There were no significant changes in any of the objective micturition parameters in women with stress incontinence following treatment. Karyopyknotic index and the presence of lactobacilli were increased (p less than 0.001), and vaginal pH decreased (p less than 0.001) following treatment in women with all types of incontinence. More than 70% of all the women treated in this algorithm model judged themselves to be improved, much improved or cured.
Molander
U
U
Department of Geriatrics, University of Göteborg, Sweden.
Milsom
I
I
Ekelund
P
P
Arvidsson
L
L
Eriksson
O
O
D000368:Aged; D000465:Algorithms; D002985:Clinical Protocols; D004964:Estriol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D013548:Sweden / Q000453:epidemiology; D014549:Urinary Incontinence / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology
D004964:Estriol